The debate surrounding cancer endpoints has focused on the issue of quality of life and progression. Panelists shared some of the challenges in assessing quality of life, since it can be a fickle and subjective process. The data can be hard to nail down since patients don’t always fill out the forms. The critical issues include survival rates, improved quality of life and progression of disease. Everything must be taken into consideration to determine endpoints, which is why the issue is hotly debated.
Subscribe to our e-newsletterVIEW OUR CURRENT ISSUE >
Tagsclimate change healthcare BIO Events biotechnology Benefits of biotech crops BIO Investor Forum Health Care Plant biotechnology Partnering Sustainability Industry Analysis Biotechnology Industry BIOTECH 2014 BIO International Convention Food BIO BIO International Convention global food crisis health biofuels
- Most Popular
Latest VideoLooking Forward to BIO 2015 View All >